The Clinic for Assessment of Youth at Risk (CAYR): 10 years of service delivery and research targeting the prevention of psychosis in Montreal, Canada

Early Intervention in Psychiatry

Volumn 11, Issue 2, 2017, Pages 177-184

  Pruessner, Marita ^a,b   Faridi, Kia ^a,b   Shah, Jai ^a,b   Rabinovitch, Mark ^a,b   Iyer, Srividya ^a,b   Abadi, Sherezad ^a   Pawliuk, Nicole ^a   Joober, Ridha ^a,b   Malla, Ashok K ^a,b  

^a DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

CAYR; indicated prevention; psychosocial intervention; stress; ultra high risk for psychosis

Indexed keywords

NEUROLEPTIC AGENT;

ANXIETY DISORDER; ARTICLE; BRIEF PSYCHIATRIC RATING SCALE; CANADA; CLINIC FOR ASSESSMENT OF YOUTH AT RISK; CLINICAL ASSESSMENT TOOL; COGNITIVE BEHAVIORAL THERAPY; COMPREHENSIVE ASSESSMENT OF AT RISK MENTAL STATES; CONCEPTUAL FRAMEWORK; COPING BEHAVIOR; DEPRESSION; DISEASE SEVERITY; EARLY INTERVENTION; GLOBAL ASSESSMENT OF FUNCTIONING; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HIGH RISK PATIENT; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MEDICAL RESEARCH; PATIENT REFERRAL; PSYCHOEDUCATION; PSYCHOSIS; RATING SCALE; SCALE FOR ASSESSMENT OF NEGATIVE SYMPTOM; SELF ESTEEM; SOCIAL SUPPORT; SUPPORT GROUP; ADOLESCENT; ADULT; EARLY DIAGNOSIS; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; MENTAL HEALTH; PROTECTION; PSYCHOLOGY; PSYCHOMETRY; PSYCHOTIC DISORDERS; QUEBEC; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; EARLY DIAGNOSIS; EARLY MEDICAL INTERVENTION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MENTAL STATUS SCHEDULE; PROTECTIVE FACTORS; PSYCHOMETRICS; PSYCHOTIC DISORDERS; QUEBEC; REFERRAL AND CONSULTATION; RISK ASSESSMENT; YOUNG ADULT;

EID: 84947997806     PISSN: 17517885     EISSN: 17517893     Source Type: Journal    
DOI: 10.1111/eip.12300     Document Type: Article

References (43)

1. McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N Z J Psychiatry 2006; 40: 616–622.
2. Malla AK, Norman RM. Prodromal symptoms in schizophrenia. Br J Psychiatry 1994; 164: 487–493.
3. Norman RM, Malla AK. Prodromal symptoms of relapse in schizophrenia: a review. Schizophr Bull 1995; 21: 527–539.
4. Yung AR, Phillips LJ, McGorry PD et al. Prediction of psychosis. A step towards indicated prevention of schizophrenia. Br J Psychiatry Suppl 1998; 172: 14–20.
5. McGorry PD. The recognition and optimal management of early psychosis: an evidence-based reform. World Psychiatry 2002; 1: 76–83.
6. Iyer S, Jordan G, MacDonald K, Joober R, Malla A. Early intervention for psychosis: a Canadian perspective. J Nerv Ment Dis 2015; 203: 356–364.
7. Fusar-Poli P, Bonoldi I, Yung AR et al. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry 2012; 69: 220–229.
8. Fusar-Poli P, Borgwardt S, Bechdolf A et al. The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry 2013; 70: 107–120.
9. Corcoran C, Walker E, Huot R et al. The stress cascade and schizophrenia: etiology and onset. Schizophr Bull 2003; 29: 671–692.
10. Walker EF, Diforio D. Schizophrenia: a neural diathesis-stress model. Psychol Rev 1997; 104: 667–685.
11. Malla AK, Norman RM, Manchanda R et al. One year outcome in first episode psychosis: influence of DUP and other predictors. Schizophr Res 2002; 54: 231–242.
12. Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry 2005; 62: 975–983.
13. Yung AR, Yuen HP, McGorry PD et al. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust N Z J Psychiatry 2005; 39: 964–971.
14. Miller TJ, McGlashan TH, Rosen JL et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull 2003; 29: 703–715.
15. Ventura J, Nuechterlein KH, Subotnik KL, Gutkind D, Gilbert EA. Symptom dimensions in recent-onset schizophrenia and mania: a principal components analysis of the 24-item Brief Psychiatric Rating Scale. Psychiatry Res 2000; 97: 129–135.
16. Andreasen NC. The Scale for Assessment of Negative Symptoms (SANS). Iowa City: The University of Iowa; 1983.
17. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382–389.
18. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56–62.
19. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429–435.
20. Luborsky L. Clinician's judgments of mental health. Arch Gen Psychiatry 1962; 7: 407–417.
21. Rosenberg SD, Drake RE, Wolford GL et al. Dartmouth Assessment of Lifestyle Instrument (DALI): a substance use disorder screen for people with severe mental illness. Am J Psychiatry 1998; 155: 232–238.
22. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption–II. Addiction 1993; 88: 791–804.
23. Skinner HA. The drug abuse screening test. Addict Behav 1982; 7: 363–371.
24. Goldberg DP, Williams P. A User's Guide to the General Health Questionnaire. Windsor UK: NFER-Nelson, 1988.
25. Schulz P, Schlotz W. The Trier Inventory for the Assessment of Chronic Stress (TICS). Scale construction, statistical testing, and validation of the scale work overload. Diagnostica 1999; 45: 8–19.
26. Reynolds WM, Koback KA. Hamilton Depression Inventory (HDI). Odessa, FL: Psychological Assessment Resources, 1995.
27. Nugent WR, Thomas JW. Validation of a clinical measure of self-esteem. Res Soc Work Pract 1993; 3: 191–207.
28. Carver CS. You want to measure coping but your protocol's too long: consider the brief COPE. Int J Behav Med 1997; 4: 92–100.
29. Zimet GD, Dahlem NW, Zimet SG, Farley GK. The Multidimensional Scale of Perceived Social Support. J Pers Assess 1988; 52: 30–41.
30. Parker G, Tupling H, Brown LB. A Parental Bonding Instrument. Br J Med Psychol 1979; 52: 1–10.
31. McGovern MP, Morrison DH. The Chemical Use, Abuse, and Dependence Scale (CUAD). Rationale, reliability, and validity. J Subst Abuse Treat 1992; 9: 27–38.
32. Liu CC, Demjaha A. Antipsychotic interventions in prodromal psychosis: safety issues. CNS Drugs 2013; 27: 197–205.
33. McGorry PD, Nelson B, Amminger GP et al. Intervention in individuals at ultra-high risk for psychosis: a review and future directions. J Clin Psychiatry 2009; 70: 1206–1212.
34. Woods SW, Addington J, Bearden CE et al. Psychotropic medication use in youth at high risk for psychosis: comparison of baseline data from two research cohorts 1998–2005 and 2008–2011. Schizophr Res 2013; 148: 99–104.
35. Sledge WH, Astrachan B, Thompson K, Rakfeldt J, Leaf P. Case management in psychiatry: an analysis of tasks. Am J Psychiatry 1995; 152: 1259–1265.
36. McFarlane WR, Lukens E, Link B et al. Multiple-family groups and psychoeducation in the treatment of schizophrenia. Arch Gen Psychiatry 1995; 52: 679–687.
37. Norman RM, Malla AK. Stressful life events and schizophrenia: II. Conceptual and methodological issues. Br J Psychiatry 1993; 162: 166–174.
38. Norman RM, Malla AK. Stressful life events and schizophrenia: I. A review of the research. Br J Psychiatry 1993; 162: 161–166.
39. Pruessner M, Iyer SN, Faridi K, Joober R, Malla AK. Stress and protective factors in individuals at ultra-high risk for psychosis, first episode psychosis and healthy controls. Schizophr Res 2011; 129: 29–35.
40. Pruessner M, Bechard-Evans L, Boekestyn L, Iyer SN, Pruessner JC, Malla AK. Attenuated cortisol response to acute psychosocial stress in individuals at ultra-high risk for psychosis. Schizophr Res 2013; 146: 79–86.
41. Andrews J, D'Aguiar C, Pruessner JC. The combined dexamethasone/TSST paradigm – a new method for psychoneuroendocrinology. PLoS ONE 2012; 7: e38994.
42. Pruessner M, Lepage M, Collins DL, Pruessner JC, Joober R, Malla AK. Reduced hippocampal volume and hypothalamus-pituitary-adrenal axis function in first episode psychosis: evidence for sex differences. Neuroimage Clin 2015; 7: 195–202.
43. Pruessner M, Vracotas N, Joober R, Pruessner JC, Malla AK. Blunted cortisol awakening response in men with first episode psychosis: relationship to parental bonding. Psychoneuroendocrinology 2013; 38: 229–240.